Table 3 Cox proportional hazards model estimates in the genotyped FINRISK testing subset and Estonian validation cohort in relation to all-cause mortality.

From: A data-driven medication score predicts 10-year mortality among aging adults

Model

FINRISK (testing subset with genotypes)

Estonian Biobank

Components

Medications

Comorbidities

Polygenic risk scores

HRMed

HRComorb

C-index

p-value (removed variables)

HRMed

HRComorb

C-index

p-value (removed variables)

BL

     

0.779 (0.757–0.801)

   

0.775 (0.767–0.784)

 

BL + CI

 

  

1.76 (1.56–1.98)

0.794 (0.773–0.815)

2.80e−16 (CI)

 

1.15 (1.13–1.17)

0.790 (0.782–0.798)

2.16e−49 (CI)

BL + M

  

1.18 (1.14–1.22)

 

0.794 (0.773–0.815)

2.25e−16 (M)

1.19 (1.17–1.22)

 

0.791 (0.783–0.799)

3.82e−69 (M)

BL + M + CI

 

1.13 (1.08–1.17)

1.50 (1.31–1.70)

0.802 (0.781–0.822)

2.49e−8 (M)

3.15e−8 (CI)

1.15 (1.12–1.17)

1.09 (1.06–1.11)

0.796 (0.788–0.804)

1.13e−46 (M)

8.13e−17 (CI)

BL + M + CI + PRS

1.13 (1.08–1.17)

1.50 (1.31–1.70)

0.803 (0.782–0.823)

0.69 (PRS)

    
  1. B baseline (age and sex covariates), M medication score, CI Charlson Comorbidity Index, PRS polygenic risk scores. Confidence intervals (95%) for estimates provided where applicable.